Successful implantation of bioengineered, intrinsically innervated, human internal anal sphincter

Gastroenterology. 2011 Jul;141(1):310-9. doi: 10.1053/j.gastro.2011.03.056. Epub 2011 Apr 2.

Abstract

Background & aims: To restore fecal continence, the weakened pressure of the internal anal sphincter (IAS) must be increased. We bioengineered intrinsically innervated human IAS to emulate sphincteric physiology in vitro.

Methods: We cocultured human IAS circular smooth muscle with immortomouse fetal enteric neurons. We investigated the ability of bioengineered innervated human IAS, implanted in RAG1-/- mice, to undergo neovascularization and preserve the physiology of the constituent myogenic and neuronal components.

Results: The implanted IAS was neovascularized in vivo; numerous blood vessels were observed with no signs of inflammation or infection. Real-time force acquisition from implanted and preimplant IAS showed distinct characteristics of IAS physiology. Features included the development of spontaneous myogenic basal tone; relaxation of 100% of basal tone in response to inhibitory neurotransmitter vasoactive intestinal peptide (VIP) and direct electrical field stimulation of the intrinsic innervation; inhibition of nitrergic and VIPergic electrical field-induced relaxation (by antagonizing nitric oxide synthesis or receptor interaction); contraction in response to cholinergic stimulation with acetylcholine; and intact electromechanical coupling (evidenced by direct response to potassium chloride). Implanted, intrinsically innervated bioengineered human IAS tissue preserved the integrity and physiology of myogenic and neuronal components.

Conclusions: Intrinsically innervated human IAS bioengineered tissue can be successfully implanted in mice. This approach might be used to treat patients with fecal incontinence.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Anal Canal / blood supply
  • Anal Canal / drug effects
  • Anal Canal / innervation*
  • Anal Canal / transplantation*
  • Animals
  • Bioartificial Organs*
  • Cells, Cultured
  • Cholinergic Agonists / pharmacology
  • Coculture Techniques
  • Electric Stimulation
  • Enzyme Inhibitors / pharmacology
  • Gastrointestinal Motility
  • Graft Survival*
  • Homeodomain Proteins / genetics
  • Homeodomain Proteins / metabolism
  • Hormone Antagonists / pharmacology
  • Humans
  • Mice
  • Mice, Knockout
  • Muscle Contraction
  • Muscle Relaxation
  • Muscle, Smooth / blood supply
  • Muscle, Smooth / drug effects
  • Muscle, Smooth / innervation*
  • Muscle, Smooth / transplantation*
  • Neovascularization, Physiologic
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / metabolism
  • Receptors, Vasoactive Intestinal Peptide / antagonists & inhibitors
  • Receptors, Vasoactive Intestinal Peptide / metabolism
  • Time Factors
  • Tissue Engineering / methods*
  • Transplantation, Heterologous
  • Vasoactive Intestinal Peptide / metabolism

Substances

  • Cholinergic Agonists
  • Enzyme Inhibitors
  • Homeodomain Proteins
  • Hormone Antagonists
  • Receptors, Vasoactive Intestinal Peptide
  • RAG-1 protein
  • Vasoactive Intestinal Peptide
  • Nitric Oxide Synthase